PubRank
Search
About
Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
Clinical Trial ID NCT03672305
PubWeight™ 0.00
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT03672305
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Toxicity and response criteria of the Eastern Cooperative Oncology Group.
Am J Clin Oncol
1982
43.81
2
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.
Blood
2011
8.26
3
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.
Blood
2011
7.49
4
Natural innate and adaptive immunity to cancer.
Annu Rev Immunol
2011
7.09
5
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Sci Transl Med
2014
5.60
6
Antibody-modified T cells: CARs take the front seat for hematologic malignancies.
Blood
2014
2.84
7
Current concepts in the diagnosis and management of cytokine release syndrome.
Blood
2014
2.63
8
Treating cancer with genetically engineered T cells.
Trends Biotechnol
2011
1.83
9
Managing cytokine release syndrome associated with novel T cell-engaging therapies.
Cancer J
2014
1.64
10
Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.
Clin Liver Dis
2015
1.51
11
Fifteen years of gene therapy based on chimeric antigen receptors: "are we nearly there yet?".
Hum Gene Ther
2009
1.44
12
Toxicities of chimeric antigen receptor T cells: recognition and management.
Blood
2016
1.07
13
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.
Trends Mol Med
2015
0.96
14
Combinatorial immunotherapy strategies for hepatocellular carcinoma.
Curr Opin Immunol
2016
0.81
15
Chimeric antigen receptor T-cell therapy to target hematologic malignancies.
Cancer Res
2014
0.80
16
Hepatocellular carcinoma and hepatitis B surface protein.
World J Gastroenterol
2016
0.79
Next 100